Ayr Wellness Inc. (AYRWF)
(Delayed Data from OTC)
$1.71 USD
+0.10 (6.21%)
Updated Aug 8, 2024 11:53 AM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Ayr Wellness Inc. (AYRWF) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$4.67 | $8.00 | $2.52 | 190.06% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Ayr Wellness Inc. comes to $4.67. The forecasts range from a low of $2.52 to a high of $8.00. The average price target represents an increase of 190.06% from the last closing price of $1.61.
Analyst Price Targets (3 )
Broker Rating
Ayr Wellness Inc. currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.75 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, two are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 50% and 25% of all recommendations. A month ago, Strong Buy made up 50%, while Buy represented 25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/23/2024 | Seaport Research Partners | Sonny Randhawa | Strong Buy | Strong Buy |
3/14/2024 | Roth Capital Partners | Scott Fortune | Strong Buy | Strong Buy |
2/8/2024 | Needham & Company | Matthew R Mcginley | Hold | Hold |
11/17/2023 | Canaccord Genuity | Matt Bottomley | Moderate Buy | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.75 |
ABR (Last week) | 1.75 |
# of Recs in ABR | 4 |
Average Target Price | $4.67 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 86 of 253 |
Current Quarter EPS Est: | -0.24 |